Healthcare & Medical Devices Global On demand · 24-48h

Global Sterile Processing Department (SPD) Service for Medical Devices Market Strategic Research Report

Global Sterile Processing Department (SPD) Service for Medic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Sterile Processing Department (SPD) Service for Medical Devices Market
$39.21B2025
8.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: High-temperature Sterilization, Low-temperature Sterilization, Other

By Application: Hard Instruments, Soft Instruments, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: STERIS, Crothall Healthcare, Sterigenics (Sotera Health), SERVIZI ITALIA S.P.A., AIR WATER INC, Nihon Stery, Inc (H.U. Group), Servizi Ospedalieri, Shanghai Julikang, PENTAX Medical, Laoken Medical Technology, SpecialtyCare, Steriguard, Antesu, IHSS, Apperton, Instruclean GmbH, Cretex Companies, Life Science Outsourcing, Surgical Solutions, Steritalia S.p.A. (DUSSMANN), Scapa Healthcare, MVO Stérilisation, Jinghong Medical, BGS Beta-Gamma-Service GmbH, Servica, Medistri SA

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 177 pages
Market size 2025
$39.21B
Billion USD
Forecast CAGR
8.4%
2025-2032
Forecast 2032
$69B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Sterile Processing Department (SPD) Service for Medical Devices market size is predicted to grow from US$ 39,214 million in 2025 to US$ 68,963 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Sterile Processing Department (SPD) service refers to the professional, standardized, and often outsourced or managed service offering that provides end-to-end processing of reusable medical and surgical instruments, ensuring they are cleaned, disinfected, sterilized, tracked, stored, and delivered in full compliance with healthcare regulations and infection-control standards.

For large hospitals, despite having the capacity for sterilization supply, the increasing demands for sophisticated instrument sterilization and the growing volume of surgeries, coupled with limitations in space expansion and operating costs, are gradually revealing the capacity bottlenecks and technological upgrade pressures of self-built Sterile Processing Departments (SPDs). Third-party Sterile Processing Departments (SPDs), with their concentrated investment in high-end equipment and professional technical teams, can undertake complex sterilization tasks, helping hospitals free up internal resources and focus on core diagnostic and treatment services. For small and medium-sized medical institutions, often limited by funding and scale, the construction and maintenance costs of standardized Sterile Processing Departments (SPDs) are difficult to bear. Self-conducting sterilization services can easily lead to substandard quality and weak risk control. Third-party Sterile Processing Departments (SPDs) effectively reduce unit service costs by consolidating scattered sterilization needs into a large-scale service, enabling small and medium-sized medical institutions to obtain sterilization services that meet national standards with lower investment, thus reducing operational burdens and mitigating infection control risks.

Policy guidance and regulation have laid a solid foundation for the development of third-party sterile processing departments (SPDs), while the urgent need of medical institutions to reduce costs and increase efficiency constitutes the core driving force for industry growth. Under the combined effect of these two factors, third-party sterile processing departments (SPDs) will gradually achieve full coverage of their service scope and a comprehensive upgrade of their service capabilities, becoming an important supporting force for ensuring medical safety and promoting high-quality development of medical services.

SPD services may be delivered in-house, managed by third-party providers, or off-site (centralized or regional sterile processing centers), supporting hospitals, ambulatory surgery centers (ASCs), clinics, and dental facilities.

Global key Sterile Processing Department (SPD) Service for Medical Devices players cover STERIS, Crothall Healthcare, Sterigenics (Sotera Health), SERVIZI ITALIA S.P.A., AIR WATER INC, etc.

This report presents a comprehensive overview of the global Sterile Processing Department (SPD) Service for Medical Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • High-temperature Sterilization
  • Low-temperature Sterilization
  • Other

Segment by Service Content

  • Comprehensive Services
  • Specialized Services

Segment by Application

  • Hard Instruments
  • Soft Instruments
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Sterile Processing Department (SPD) Service for Medical Devices market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hard Instruments, Soft Instruments, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Sterile Processing Department (SPD) Service for Medical Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$39.21B
2025
Forecast
$69B
2032
CAGR
8.4%
2025–2032
Regions
5
global
Key companies
STERISCrothall HealthcareSterigenics (Sotera Health)SERVIZI ITALIA S.P.A.AIR WATER INCNihon SteryInc (H.U. Group)Servizi Ospedalieri
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
High-temperature SterilizationLow-temperature SterilizationOther
By Application
Hard InstrumentsSoft InstrumentsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 High-temperature Sterilization
  • 3.1.3 Low-temperature Sterilization
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hard Instruments
  • 4.1.3 Soft Instruments
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 STERIS
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Crothall Healthcare
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sterigenics (Sotera Health)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 SERVIZI ITALIA S.P.A.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 AIR WATER INC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Nihon Stery , Inc (H.U. Group)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Servizi Ospedalieri
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shanghai Julikang
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 PENTAX Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Laoken Medical Technology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 SpecialtyCare
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Steriguard
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Antesu
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 IHSS
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Apperton
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Instruclean GmbH
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Cretex Companies
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Life Science Outsourcing
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Surgical Solutions
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Steritalia S.p.A. (DUSSMANN)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Scapa Healthcare
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 MVO Stérilisation
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Jinghong Medical
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 BGS Beta-Gamma-Service GmbH
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Servica
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 Medistri SA
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Sterile Processing Department (SPD) Service for Medical Devices market size?
The global Sterile Processing Department (SPD) Service for Medical Devices market is estimated at US$ 39.21 billion in 2025 (base year) and is projected to reach US$ 68.96 billion by 2032.
What growth rate is expected for the Sterile Processing Department (SPD) Service for Medical Devices market through 2032?
The market is expected to grow at a CAGR of 8.4% from 2026 to 2032, expanding from US$ 39.21 billion in 2025 to US$ 68.96 billion in 2032, roughly 1.8 times its base-year value.
How is Sterile Processing Department (SPD) Service for Medical Devices defined?
Sterile Processing Department (SPD) service refers to the professional, standardized, and often outsourced or managed service offering that provides end-to-end processing of reusable medical and surgical instruments, ensuring they are cleaned, disinfected, sterilized, tracked, stored, and delivered in full compliance with healthcare regulations and infection-control standards.
What are the main segments of the Sterile Processing Department (SPD) Service for Medical Devices market by type?
By type, the market is segmented into High-temperature Sterilization, Low-temperature Sterilization and Other.
Which applications drive demand in the Sterile Processing Department (SPD) Service for Medical Devices market?
Key applications covered include Hard Instruments, Soft Instruments and Others.
Who are the key players in the Sterile Processing Department (SPD) Service for Medical Devices market?
Key players profiled include STERIS, Crothall Healthcare, Sterigenics (Sotera Health), SERVIZI ITALIA S.P.A., AIR WATER INC, Nihon Stery , Inc (H.U. Group), Servizi Ospedalieri and Shanghai Julikang, among 26 companies covered in total.
Which regions and countries are covered for Sterile Processing Department (SPD) Service for Medical Devices?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Sterile Processing Department (SPD) Service for Medical Devices market?
Policy guidance and regulation have laid a solid foundation for the development of third-party sterile processing departments (SPDs), while the urgent need of medical institutions to reduce costs and increase efficiency constitutes the core driving force for industry growth.
What challenges does the Sterile Processing Department (SPD) Service for Medical Devices market face?
For large hospitals, despite having the capacity for sterilization supply, the increasing demands for sophisticated instrument sterilization and the growing volume of surgeries, coupled with limitations in space expansion and operating costs, are gradually revealing the capacity bottlenecks and technological upgrade pressures of self-built Sterile Processing Departments (SPDs).
Who should buy the Sterile Processing Department (SPD) Service for Medical Devices market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hard Instruments, Soft Instruments and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Sterile Processing Department (SPD) Service for Medical Devices market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.